Med Life SA Cash Flow Conversion Efficiency
Med Life SA cash flow conversion efficiency. Based on the latest financial reports, Med Life SA (M) has a cash flow conversion efficiency ratio of 0.146x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RON73.52 Million ≈ $16.88 Million USD) by net assets (RON502.03 Million ≈ $115.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see M company net worth for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Med Life SA (2020–2024)
Cash flow conversion efficiency of Med Life SA from 2020 to 2024. This chart illustrates how Med Life SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View M stock price and chart for real-time trading data and today's change.
Med Life SA Cash Flow Conversion Ratio Explained
Med Life SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Med Life SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Med Life SA ranked by their cash flow conversion efficiency. Review Med Life SA free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ShanXi Coking Co Ltd
SHG:600740
|
0.010x |
|
Unilever PLC
LSE:ULVR
|
0.125x |
|
Fufeng Group Limited
F:FFO1
|
0.034x |
|
Tibet Tianlu Co Ltd
SHG:600326
|
0.030x |
|
C&S Paper Co Ltd
SHE:002511
|
0.142x |
|
Dis-Chem Pharmacies
JSE:DCP
|
0.341x |
|
Mitra Adiperkasa Tbk
JK:MAPI
|
0.124x |
|
HIAG Immobilien Holding AG
SW:HIAG
|
0.015x |
Annual Cash Flow Conversion Efficiency for Med Life SA (2020–2024)
The table below shows the annual cash flow conversion efficiency of Med Life SA from 2020 to 2024. Also see Med Life SA assets under control for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-09-30 | RON507.29 Million ≈ $116.48 Million |
RON276.31 Million ≈ $63.44 Million |
0.545x | +46.68% |
| 2023-09-30 | RON494.19 Million ≈ $113.47 Million |
RON183.51 Million ≈ $42.14 Million |
0.371x | -3.04% |
| 2022-09-30 | RON482.04 Million ≈ $110.68 Million |
RON184.62 Million ≈ $42.39 Million |
0.383x | -35.76% |
| 2021-09-30 | RON381.40 Million ≈ $87.58 Million |
RON227.40 Million ≈ $52.21 Million |
0.596x | +24.61% |
| 2020-09-30 | RON268.91 Million ≈ $61.75 Million |
RON128.66 Million ≈ $29.54 Million |
0.478x | -- |
About Med Life SA
Med Life S.A., a private healthcare provider, provides healthcare services through its clinics and hospitals in Bucharest, Cluj, Braila, Timisoara, Iasi, Galati, Ploiesti, Constanta, and Targu Mures, Romania. The company offers outpatient units and diagnostic imaging services; consultations with general practitioners and specialists; diagnostic imaging investigations; day hospitalization services… Read more